Jan 25, 2013, 10.27 AM | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Dr Reddys Laboratories.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
Sukhani told CNBC-TV18, "Dr Reddys Laboratories is now on the verge of making lifetime new highs. It has been doing that. It has been a relatively laid back stock, but it is going up. For 2-3 days it has been in a narrow range. Yesterday it just inched up crossing that resistance level moving towards new highs. That seems to be the sign that a big upmove is coming. So it is not just a day trade. I would think that traders who are willing should take a position and carry it over to next week."
The share touched its 52-week high Rs 1,952 and 52-week low Rs 1,555 on 16 January, 2013 and 19 June, 2012, respectively. Currently, it is trading 0.4% below its 52-week high and 25.03% above its 52-week low. Market capitalisation stands at Rs 33,019.61 crore.
Disclosure: I have no holdings in the above stock.
Dr Reddy's Laboratories Ltd has informed BSE that
"ZembraceSymTouch is the first branded product in
The company said the buyback of equity shares will
Exports of pharma although grew by 9.7 per cent bu
Almost every major drug company was pulled up by t
Watch the interview of Renisha Chainani of Edelwei
Ashwani Gujral of ashwanigujral.com recommends buy